Study design and setting
lung cancer
LUNG CANCER
This randomised (1:1:1), assessor-blinded, controlled trial compared three parallel groups of patients with lung cancer who underwent surgical resection. This study was approved by the Ethics Committee of the hospital, under reference number B2020-173-01, and submitted to the clinical trial database (clinicaltrials.gov; registration number: NCT04914624) on 04/06/2021. All procedures in this study were conducted in accordance with the principles of the Declaration of Helsinki.